• Explore /
  • Poster
  • / Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use program in France.

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use program in France.

Abstract Poster

Authors

null

Nadine Houede

CHU Carémeau, Nîmes, France

Nadine Houede , Philippe Beuzeboc , Sophie Gourgou , Diego Tosi , Laura Moise , Gwenaelle Gravis , Remy Delva , Aude Flechon , Igor Latorzeff , Jean-Marc Ferrero , Stephane Oudard , Sophie Tartas , Brigitte Laguerre , Delphine Topart , Guilhem Roubaud , Hanane Agherbi , Xavier Rebillard , David Azria

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 264)

DOI

10.1200/jco.2015.33.7_suppl.264

Abstract #

264

Poster Bd #

D7

Abstract Disclosures

Similar Posters

First Author: Tilman Todenhöfer

First Author: Emily Nash Smyth

First Author: Russell Kent Pachynski

First Author: Syed A. Hussain